Home / Department of Immunology and Infectious Diseases / Events / When essential isn’t good enough: new strategies for target-based drug discovery in M. tuberculosis and beyond

September 25

When essential isn’t good enough: new strategies for target-based drug discovery in M. tuberculosis and beyond

Location

room FXB 301

Time

12:00 pm – 1:00 pm

Event Type

+ Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Barbara Bosch MD, PhD

Instructor in Clinical Investigation, The Rockefeller University

“As a physician-scientist with academic training in clinical medicine and research experience in basic sciences, I strongly believe that translational research is needed to bridge the gap between scientific discovery and clinical medicine.”

THIS SPEAKER WILL BE IN PERSON IN FXB 301.
The event will be hybrid and we will have lunch for those that are present.